India’s medical-device industry is making a serious global play exports surged to $3.8 billion in 2024, local manufacturing is scaling up fast, and policies like PLI plus Make-in-India are fueling innovation. With its footprint now expanding, India aims to capture 10–12% of the global MedTech market over the next 25 years.
Glimpse:
India is transforming its MedTech narrative. The country’s medical-device exports have climbed to $3.8 billion, while domestic production now meets nearly a third of national demand. Fueled by government initiatives and cost-competitive manufacturing, India is targeting 10–12% of the global medical-technology market in the coming decades. This shift positions the nation as a future powerhouse in affordable, high-quality device innovation
India’s medical-device industry is emerging from the shadows once heavily reliant on imports, the country is now confidently pushing for a seat at the global MedTech table. With exports reaching $3.8 billion in 2024, the world is starting to take notice of India’s manufacturing and innovation muscle.
A key driver of this transformation is India’s manufacturing strength. Backed by initiatives like Make-in-India, and favorable investment policies, the country is rapidly building capacity for high-end devices. Domestic production now covers about 30% of India’s own medical-device needs, up from under 10% just a few years ago.
It’s not just volume India is innovating too. The industry is projected to grow to $50 billion by 2030, with ambitious plans to capture 10-12% of the global MedTech market over the next 25 years. Factors behind this growth include a skilled workforce, cost-effective production, and strong R&D foundations.
This global push is also supported by favorable regulation: 100% FDI is allowed in medical-device manufacturing, and several greenfield production parks are being established to support scale. Analysts believe that India’s cost-competitive, high-volume device production especially for disposables and consumables can make it a go-to source for global markets.
The road ahead isn’t without challenges high-technology imports still dominate, and the country needs to continue investing in R&D, regulatory strength, and quality assurance. But with its momentum, India may soon be defining what “affordable innovation” means in global health.
“India is no longer just a MedTech buyer we’re building the capabilities to lead and export globally. Our strength lies in innovation, scale, and affordability.”
By
HB Team
Related News
